ERS International Congress, Milan 2017

Browse by day:
Saturday, 09.09.2017
Sunday, 10.09.2017
Monday, 11.09.2017
Tuesday, 12.09.2017
Wednesday, 13.09.2017

 

Sponsored symposia:

Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.


Controversies in community-acquired pneumonia: a pro and con debate

Symposium
Chairs: Francesco Blasi (Milan, IT), Martin Witzenrath (Berlin, DE)
Should lung ultrasound replace chest X-ray in diagnosing pneumonia? Pro argument
Daniel Lichtenstein (PARIS, France)
Slide presentation
Slide presentation
Should lung ultrasound replace chest X-ray in diagnosing pneumonia? Con argument
Gebhard Mathis (Rankweil, Austria)
WebcastSlide presentation
WebcastSlide presentation
Should macrolides be given to all patients with community-acquired pneumonia? Pro argument
Antonio Anzueto (San Antonio, United States of America)
WebcastSlide presentation
WebcastSlide presentation
Should macrolides be given to all patients with community-acquired pneumonia? Con argument
Mark Andrew Woodhead (Manchester, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Should steroids be used in community-acquired pneumonia? Pro argument
Antoni Torres (Barcelona, Spain)
WebcastSlide presentation
WebcastSlide presentation
Should steroids be used in community-acquired pneumonia? Con argument
Grant Waterer (Perth, WA, Australia)
WebcastSlide presentation
WebcastSlide presentation
Should severe CAP patients receive anti-MRSA coverage? Pro argument
Marcos I. Restrepo (San Antonio, United States of America)
WebcastSlide presentation
WebcastSlide presentation
Should severe CAP patients receive anti-MRSA coverage? Con argument
Tobias Welte (Hannover, Germany)
Slide presentation
Slide presentation